Lance L. Jelks

Lance L. Jelks serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions within the medical technology sector. He ensures compliance with federal procurement regulations while facilitating timely and effective contract award and administration. His portfolio centers on high-precision medical devices and diagnostic solutions, requiring deep technical understanding and rigorous source selection processes. Jelks plays a critical role in aligning procurement activities with agency mission needs, ensuring that acquisitions support public health objectives through transparent, compliant, and efficient contracting practices. Jelks collaborates extensively with manufacturers and suppliers specializing in in-vitro diagnostics, electromedical equipment, and surgical instruments. While no single contractor dominates his portfolio, he consistently engages with a diverse pool of small businesses and mid-tier vendors capable of meeting stringent FDA and ISO regulatory standards. His working relationships are characterized by proactive communication, early vendor engagement during requirements development, and a focus on performance-based contracting to ensure product reliability and clinical efficacy. Jelks demonstrates an unwavering commitment to small business participation, with 100% of his acquisitions structured as total small business set-asides under FAR 19.5. This reflects a deliberate strategy to maximize economic opportunity for small manufacturers and foster innovation within the medical device supply chain. He actively promotes socioeconomic contracting goals by prioritizing firms certified under HUBZone, SDVOSB, and other small business programs, ensuring equitable access to federal procurement opportunities. His primary procurement focus lies in NAICS 325413 (in-vitro diagnostic substances), 334510 (electromedical and electrotherapeutic apparatus), and 339112 (surgical and medical instruments), each representing approximately one-third of his activity. He specializes in acquiring Class II and III medical devices requiring premarket notification or approval, with a strong emphasis on quality systems compliance, supply chain resilience, and clinical utility. Jelks brings technical acumen to procurement decisions, ensuring that acquisitions meet both regulatory and operational demands of healthcare delivery systems.